In November, the Central Drugs Standard Control Organisation (CDSCO) identified 41 drug samples as not of standard quality (NSQ), while state drug testing laboratories identified 70 NSQ samples. Additionally, two drug samples were found to be spurious, made by unauthorized manufacturers. Authorities regularly collaborate with state regulators to remove such drugs from the market.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yuXw73d
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» 111 drug samples tested in November found 'not of standard quality'
0 comments:
Post a Comment